Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV)
- 19 July 2013
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 229 (1) , 34-43
Abstract
Few options are available for treating patients with advanced prostate cancer (PC). As PC is a slow growing disease and accessible by ultrasound, gene therapy could provide a viable option for this neoplasm. Conditionally replication‐competent adenoviruses (CRCAs) represent potentially useful reagents for treating PC. We previously constructed a CRCA, cancer terminator virus (CTV), which showed efficacy both in vitro and in vivo for PC. The CTV was generated on a serotype 5‐background (Ad.5‐CTV) with infectivity depending on Coxsackie‐Adenovirus Receptors (CARs). CARs are frequently reduced in many tumor types, including PCs thereby limiting effective Ad‐mediated therapy. Using serotype chimerism, a novel CTV (Ad.5/3‐CTV) was created by replacing the Ad.5 fiber knob with the Ad.3 fiber knob thereby facilitating infection in a CAR‐independent manner. We evaluated Ad.5/3‐CTV in comparison with Ad.5‐CTV in low CAR human PC cells, demonstrating higher efficiency in inhibiting cell viability in vitro. Moreover, Ad.5/3‐CTV potently suppressed in vivo tumor growth in a nude mouse xenograft model and in a spontaneously induced PC that develops in Hi‐myc transgenic mice. Considering the significant responses in a Phase I clinical trial of a non‐replicating Ad.5‐mda‐7 in advanced cancers, Ad.5/3‐CTV may exert improved therapeutic benefit in a clinical setting. J. Cell. Physiol. 229: 34–43, 2014.Keywords
This publication has 66 references indexed in Scilit:
- Switching the fiber knob of oncolytic adenoviruses to avoid neutralizing antibodies in human cancer patientsThe Journal of Gene Medicine, 2011
- Mechanism by Which Mcl-1 Regulates Cancer-Specific Apoptosis Triggered by mda-7/IL-24, an IL-10–Related CytokineCancer Research, 2010
- RETRACTED: Inhibition of Multiple Protective Signaling Pathways and Ad.5/3 Delivery Enhances mda-7/IL-24 Therapy of Malignant GliomaMolecular Therapy, 2010
- BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family ProteinsJournal of Medicinal Chemistry, 2010
- Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cellsCancer Gene Therapy, 2010
- Eradication of Therapy-resistant Human Prostate Tumors Using an Ultrasound-guided Site-specific Cancer Terminator Virus Delivery ApproachMolecular Therapy, 2010
- Oncolytic virus therapy for prostate cancerInternational Journal of Urology, 2009
- Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damageGene Therapy, 2003
- MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokineCytokine & Growth Factor Reviews, 2003
- mda -7 (IL-24): Signaling and Functional RolesBioTechniques, 2002